Look for an AI Writer Program
Recently, the "old players" of pharmaceutical O2O have launched new ways to play, and new players are constantly joining. The entry of new players is undoubtedly a fancy to the future incremental space of the pharmaceutical O2O market, and they expect to have the opportunity to get a piece of the pie before the market is not saturated.
For major Internet companies, the online part of pharmaceutical O2O is a strong point, and Internet companies that master the traffic password can quickly occupy their own place in the market, but the offline part will be a big challenge for some Internet companies, such as the logistics system.
Of course, at present, although the average annual compound growth rate of the entire industry looks good, but its ceiling will not be very high, according to the current business model, pharmaceutical O2O, it is difficult to extend to the pain points of the entire medical and pharmaceutical industry, for the real solution to the problem of medicine and medicine in the market, there is no good solution, so the entire market size that can be driven, the upper limit will not be high. And relying solely on traffic to do business, the dividends will gradually fade sooner or later.